GMP Guidelines for Biopharmaceuticals – a Brief Summary
- Relevant international regulations
- European biotech guidance
- Recent developments & possible impacts
GMP Requirements Applying to Biotechnological Investigational Medicinal Products (IMPs of Clinical Phases I-III & APIs for use in IMPs)
- EU regulations & guidances
- Examples of national regulations
- State-of-the-art manufacturing for clinical phases
Development of Biopharmaceuticals – GMP, Regulatory Aspects and Inspection & Audit Experiences
- EU and US guidances related to clinical trials GMP/CMC incl. Annex 13 update
- CDMO considerations on specifications
- Inspection and audit experiences “pre-approval”
Development, Qualification and Validation of Process Analytics for Biopharmaceuticals
- Relevant guidelines
- Phases of product development / testing requirements
- Method portfolio/method development / method qualification / method validation
- Product analytics & QC methods for product characterization
- Relevant guidelines & publications
GMP Inspections in Biopharmaceutical Production
- Inspections of biopharmaceutical companies
- Focus & discussion points during inspections
- Clean room classes for biotech facilities
- Open vs. closed processing
- Single- vs. multi-purpose equipment
- Cell banking activities
- Inspector’s experience, examples of observations
Process Transfer from Development to Commercial Production from a Quality Perspective
- Definition and types of Transfers
- Specific quality considerations for transfers
- Transition from “development” to “Commercial”
GMP-conform Process Development and Validation (incl. Equipment Qualification)
- Process development, manufacturing & dedicated instruments
- Current initiatives in pharmaceutical development
- Biopharmaceuticals / Biosimilars / Biologicals
- Process
- Analytical Methods
- Equipment / instruments and facility
Quality Assurance for Biopharmaceuticals
- Classical responsibilities of QA department
- Allocation of responsibilities, training of staff
- Dealing with suppliers & contractors
- The world changes: Change Management
- Shit happens: Deviation Management & CAPA
- Handling complaints & product recalls
- Paper, paper, paper: documentation works: SOPs, MBR, PQR & management report
- Surveillance of qualification & validation, calibration and maintenance
- Self inspections & auditing
Bioanalytics for Clinical Trials – Method/Process Development and Validation for Phase I – III Studies
- Definitions of terms (ICH guidelines, GCLP, GCP, GLP)
- Process development & Quality by Design
- Early clinical phases
- Late clinical phases
- Post-approval items & activities
State-of-the-art Biotechnological Manufacture (Bacteria, Yeast, Mammalian Cells) and Cell Banking Activities - Part 1
- Reasons for cell banking
- Where does GMP start?
- Characterization of cell banks
- Storage of cell banks
State-of-the-art Biotechnological Manufacture (Bacteria, Yeast, Mammalian Cells) and Cell Banking Activities - Part 2
- Overview of a typical biotech process
- Requirements on production areas, raw materials and equipment
- Specialities on biotech products
- Fill and finish
mRNA Technology – Principles, Manufacturing and Regulatory Perspective
- COVID vaccines: Viral and mRNA vaccines
- Modular principle of mRNA-based vaccines and mRNA vaccine manufacturing
- Regulatory perspective on mRNA products
- Application process for updating the MIA
- GMP challenges for new biological products
Annex 1 – Impact on the Manufacturing of Biopharmaceuticals
- Annex 1: What is the Annex 1 and why is it revised?
- Key principles of the revised Annex 1
- Impact on facility, equipment, personal, raw materials, QRM, CCS, …
- Case Study: Implementation in the daily business